QVT Financial’s Arbutus Biopharma ABUS Stock Holding History

QVT Financial’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,013,540	Closed	-$80.9M	–	54
2017 Q4	$80.9M	Hold	16,013,540	–	–	4.92%	6
2017 Q3	$99.3M	Hold	16,013,540	–	–	4.25%	6
2017 Q2	$57.6M	Hold	16,013,540	–	–	1.68%	9
2017 Q1	$52M	Hold	16,013,540	–	–	1.85%	9
2016 Q4	$39.2M	Hold	16,013,540	–	–	1.46%	11
2016 Q3	$55.1M	Buy	+16,013,540	New	+$62.6M	2.4%	8
2015 Q4	–	Sell	-16,013,540	Closed	-$97.5M	–	81
2015 Q3	$97.5M	Hold	16,013,540	–	–	4.03%	5
2015 Q2	$190M	Hold	16,013,540	–	–	6.08%	4
2015 Q1	$280M	Buy	+16,013,540	New	+$328M	20.61%	2

Other funds holding ABUS

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return